| Literature DB >> 7263069 |
C Carelli, F Audibert, L Chedid.
Abstract
Circulating antibody titers can be increased when the antigen is administered in an aqueous medium with N-acetylmuramyl-L-alanyl-D-isoglutamine (muramyl dipeptide). Results reported here show that cell-mediated immunity can be demonstrated when this synthetic adjuvant or an active analog is injected with an antigen (ovalbumin) in metabolizable squalane emulsion. Under these conditions a lipophilic derivative of muramyl dipeptide was shown to be even more active and to enhance long-lasting immune responses.Entities:
Mesh:
Substances:
Year: 1981 PMID: 7263069 PMCID: PMC350692 DOI: 10.1128/iai.33.1.312-314.1981
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441